Regeneron Pharmaceuticals Inc (REGN)
955.76
-14.21
(-1.46%)
USD |
NASDAQ |
May 08, 16:00
955.00
-0.76
(-0.08%)
After-Hours: 04:56
Regeneron Pharmaceuticals Debt to Equity Ratio: 0.0735 for March 31, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| March 31, 2024 | 0.0735 |
| December 31, 2023 | 0.0763 |
| September 30, 2023 | 0.0796 |
| June 30, 2023 | 0.0825 |
| March 31, 2023 | 0.0843 |
| December 31, 2022 | 0.0874 |
| September 30, 2022 | 0.0924 |
| June 30, 2022 | 0.0957 |
| March 31, 2022 | 0.0994 |
| December 31, 2021 | 0.1055 |
| September 30, 2021 | 0.1147 |
| June 30, 2021 | 0.1308 |
| March 31, 2021 | 0.1652 |
| December 31, 2020 | 0.1795 |
| September 30, 2020 | 0.1954 |
| June 30, 2020 | 0.1656 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| Date | Value |
|---|---|
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.0093 |
| June 30, 2015 | 0.0091 |
| March 31, 2015 | 0.0485 |
| December 31, 2014 | 0.0576 |
| September 30, 2014 | 0.1128 |
| June 30, 2014 | 0.1192 |
| March 31, 2014 | 0.1477 |
| December 31, 2013 | 0.1641 |
| September 30, 2013 | 0.1859 |
| June 30, 2013 | 0.2063 |
| March 31, 2013 | 0.2149 |
| December 31, 2012 | 0.2381 |
| September 30, 2012 | 0.361 |
| June 30, 2012 | 0.4801 |
| March 31, 2012 | 0.5559 |
| December 31, 2011 | 0.5662 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Jun 2019
0.1954
Maximum
Sep 2020
0.0914
Average
0.0899
Median
Debt to Equity Ratio Benchmarks
| Vertex Pharmaceuticals Inc | 0.00 |
| Amgen Inc | 12.75 |
| Eli Lilly and Co | 2.046 |
| Moderna Inc | 0.00 |
| Gilead Sciences Inc | 0.00 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 34.37B |
| Total Liabilities (Quarterly) | 7.378B |
| Shareholders Equity (Quarterly) | 26.99B |
| Current Ratio | 5.27 |
| Net Debt Paydown Yield | -0.00% |